Vertex Pharmaceuticals (VRTX)
$495.91
0.00 (0.00%)
VRTX Stock Quote Delayed 30 Minutes
Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons
Vertex continues to extend its dominance within cystic fibrosis treatments. But has VRTX stock run ahead of the company's potential?
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
128.65B
PE Ratio
32.18
EPS
15.41
Volume (Avg. Vol.)
73
Day's Range
-
52-Week Range
$340.20 - $498.77
Dividend & Yield
N/A (N/A)
VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News
Will Oil Prices Spoil Tesla Inc’s (TSLA) Model 3 Party?
TSLA stock has cruised for months to all-time highs, but some fear that oil's lack of momentum could cramp Tesla's upcoming EV launch.
The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch
Biotech stocks are quietly climbing higher. Here's how to trade the SPDR S&P Biotech (ETF) (XBI) before its seemingly imminent pop.
3 Stocks to Watch on Wednesday: RH (RH), Vertex Pharmaceuticals Incorporated (VRTX) and Ollie’s Bargain Outlet Holdings Inc (OLLI)
RH (RH) and Ollie's Bargain Outlet (OLLI) are headed higher on earnings, while Vertex Pharmaceuticals (VRTX) is rocketing on trial results.
Why Celgene Corporation (CELG), Nu Skin Enterprises, Inc. (NUS) and Pioneer Energy Services Corp (PES) Are 3 of Today’s Worst Stocks
Celgene (CELG), Pioneer Energy ServiceS (PES) and Nu Skin Enterprises (NUS) couldn't win for losing on this week's hump-day.
23 Biotechnology Stocks to Sell Now
This week, the ratings of 23 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
30 Biotechnology Stocks to Sell Now
The ratings of 30 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
6 Biotechnology Stocks to Sell Now
This week, 6 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
26 Biotechnology Stocks to Sell Now
The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
25 Stocks to Sell Before Earnings Season (AAPL, GILD, WFM)
We are now deep into earnings season, and I have updated rankings that suggest you consider selling these stocks ahead of earnings
73 Stock Trades for Your Week
During these times it pays to stay on top of the latest profit opportunities. Today's blog post should be a great place to start with these 73 stock trades
